EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC-ND 4.0

Imaging predictors of adverse prognosis in Fabry disease cardiomyopathy: A systematic review and meta‐analysis

Kamil Stankowski, Stefano Figliozzi iD, Thanakorn Rojanathagoon, Dimitrios Bampatsias, Dimitrios Klettas, Lorenzo Monti, Renato Bragato, Pier-Giorgio Masci, Marco Francone, Gianluigi Condorelli, Massimo Imbriaco, Maurizio Pieroni und 2 weitere

European Journal of Clinical Investigation · 2025-05 · 55 (5)

DOI: 10.1111/eci.14388 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift European Journal of Clinical Investigation, online erschienen am 22.01.2025. Verfasst von Kamil Stankowski und 13 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy. Hauptthemen laut MEDLINE: Fabry Disease, Cardiomyopathies. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cardiac involvement represents the main cause of death in patients with Fabry disease (FD). Echocardiography and cardiovascular magnetic resonance (CMR) have an established diagnostic role, but their prognostic value remains unresolved. This systematic review and meta‐analysis sought to assess the prognostic implications of imaging parameters in FD.

Methods

PubMed, ClinicalTrials.gov , Embase, Cochrane Library and Web of Science databases were searched for studies from inception through 1 May 2024. Studies including FD patients undergoing baseline imaging assessment and clinical follow‐up were selected. Pre‐defined study outcomes were a cardiovascular endpoint and a composite clinical endpoint. The study protocol was registered in PROSPERO (ID CRD42022342394).

Results

Fourteen studies, including 1713 FD patients (44.7% males), were selected. At pooled analysis, late gadolinium enhancement (hazard ratio [HR]: 4.45; 95% CI: 2.82–7.02), left atrium volume indexed (HR: 1.02 per mL/m 2 ; 95% CI: 1.01–1.03), E/e′ (HR: 1.14 per unit increase; 95% CI: 1.08–1.21), left ventricular (LV) mass indexed (HR: 1.01 per mg/m 2 ; 95% CI: 1.00–1.02), maximum LV wall thickness (HR: 1.19 per mm, 95% CI: 1.04–1.36) and LV‐global longitudinal strain (HR: 1.20 per unit increase; 95% CI: 1.16–1.25) were significantly associated with the cardiovascular endpoint, whereas T1‐mapping and LV‐ejection fraction were not. T1‐mapping was associated with the composite endpoint (HR: 0.99 per msec increase; 95% CI: 0.98–1.00). Meta‐regression analysis did not show any significant interaction between each of the potential effect modifiers.

Conclusions

Several imaging parameters were significant predictors of adverse clinical outcomes in patients with FD. Late gadolinium enhancement showed the strongest association with adverse prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fabry DiseaseCardiomyopathiesHumansPrognosisEchocardiographyMagnetic Resonance ImagingMagnetic Resonance Imaging, CineGadoliniumStroke Volume

Stichwörter der Autor:innen

Fabry diseasecardiovascular magnetic resonanceglobal longitudinal strainlate gadolinium enhancementleft ventricular hypertrophytransthoracic echocardiography

Substanzen

Gadolinium

Autor:innen und Institutionen

  • IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
  • Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
  • School of Medicine, University of Nottingham, Nottingham, UK.
  • Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
  • School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
  • Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.

ORCID-Profile: Stefano Figliozzi, Georgios Georgiopoulos

Zitieren

APA

Stankowski, K., Figliozzi, S., Rojanathagoon, T., Bampatsias, D., Klettas, D., Monti, L., Bragato, R., Masci, P. G., Francone, M., Condorelli, G., Imbriaco, M., Pieroni, M., Camporeale, A., & Georgiopoulos, G. (2025). Imaging predictors of adverse prognosis in Fabry disease cardiomyopathy: A systematic review and meta‐analysis. European Journal of Clinical Investigation, 55(5). https://doi.org/10.1111/eci.14388

Vancouver

Stankowski K, Figliozzi S, Rojanathagoon T, Bampatsias D, Klettas D, Monti L, et al. Imaging predictors of adverse prognosis in Fabry disease cardiomyopathy: A systematic review and meta‐analysis. European Journal of Clinical Investigation. 2025;55(5). doi:10.1111/eci.14388

BibTeX
@article{Stankowski2025,
  author = {Stankowski, Kamil and Figliozzi, Stefano and Rojanathagoon, Thanakorn and Bampatsias, Dimitrios and Klettas, Dimitrios and Monti, Lorenzo and Bragato, Renato and Masci, Pier-Giorgio and Francone, Marco and Condorelli, Gianluigi and Imbriaco, Massimo and Pieroni, Maurizio and Camporeale, Antonia and Georgiopoulos, Georgios},
  title = {Imaging predictors of adverse prognosis in Fabry disease cardiomyopathy: A systematic review and meta‐analysis},
  journal = {European Journal of Clinical Investigation},
  year = {2025},
  volume = {55},
  number = {5},
  doi = {10.1111/eci.14388}
}
Kostenlos starten →